Phase 1 HBV Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1
A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection
Chronic Hepatitis B Virus (Hbv)
Jiyan Liu9 enrolled1 locationNCT07051187
Recruiting
Phase 1
Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
Chronic Hepatitis BHBVChronic Hep B+1 more
Tune Therapeutics, Inc.36 enrolled3 locationsNCT06671093
Recruiting
Phase 1Phase 2
Study of LW231 in Participants With Chronic Hepatitis B
Chronic HBV Infection
Shanghai Longwood Biopharmaceuticals Co., Ltd.270 enrolled2 locationsNCT07179575
Completed
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of BJT-778 in Subjects with Chronic HBV Infection (CHB).
Chronic Hepatitis B Virus (HBV) Infection
Bluejay Therapeutics Inc.40 enrolled8 locationsACTRN12623000078651
Completed
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Healthy Volunteers.
Chronic Hepatitis D Virus (HDV) InfectionChronic Hepatitis B Virus (HBV) Infection
Bluejay Therapeutics Inc32 enrolled1 locationACTRN12623000075684
Withdrawn
Phase 1
A Study to investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AB-452 in Healthy Subjects and Subjects with Chronic HBV Infection
Chronic HBV Infection
Arbutus Biopharma Corporation76 enrolled6 locationsACTRN12618001438246
Terminated
Phase 1
A study to investigate the Safety, Tolerability, and Pharmacokinetics of AB-506 in Healthy Subjects and Subjects with Chronic HBV Infection
Chronic HBV Infection
Arbutus Biopharma Corporation76 enrolled5 locationsACTRN12618000987268